Lepu Biopharma Co., Ltd.
Clinical trials sponsored by Lepu Biopharma Co., Ltd., explained in plain language.
Biopharmaceutical company focused on innovative drugs for cardiovascular and metabolic diseases.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
Can a new drug combo shrink Hard-to-Treat colorectal tumors?
Disease control Not yet recruitingThis trial is testing whether an experimental drug called MRG007, given together with standard chemotherapy and targeted therapies, can safely shrink tumors in people with advanced colorectal cancer that cannot be removed by surgery. The study involves about 316 participants and …
Phase: PHASE1, PHASE2 • Sponsor: Lepu Biopharma Co., Ltd. • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New hope for pancreatic cancer: experimental drug MRG004A enters final testing phase
Disease control Not yet recruitingThis phase 3 trial tests whether the experimental drug MRG004A, combined with best supportive care, helps people with advanced pancreatic cancer live longer compared to a placebo. The study plans to enroll 231 adults whose cancer has not responded to standard treatments. Particip…
Phase: PHASE3 • Sponsor: Lepu Biopharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC